Literature DB >> 11090801

Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice.

A Svilaas1, K Risberg, M Thoresen, L Ose.   

Abstract

Statin drug treatment has still not achieved complete acceptance, and titration to recommended target goals is still not used by physicians in Norway.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11090801     DOI： 10.1016/s0002-9149(00)01212-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  9 in total

1.  Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).

Authors:  Shaun G Goodman; Anatoly Langer; Natacha R Bastien; Ruth McPherson; Gordon A Francis; Jacques J Genest; Lawrence A Leiter
Journal:  Can J Cardiol       Date:  2010-11       Impact factor: 5.223

2.  Undertreatment of hypercholesterolaemia: a population-based study.

Authors:  A K Mantel-Teeuwisse; W M M Verschuren; O H Klungel; D Kromhout; A D Lindemans; J Avorn; A J Porsius; A de Boer
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

3.  Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?

Authors:  Aukje K Mantel-Teeuwisse; Olaf H Klungel; W M Monique Verschuren; Arijan J Porsius; Anthonius de Boer
Journal:  Br J Clin Pharmacol       Date:  2002-04       Impact factor: 4.335

4.  Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromso study 2001.

Authors:  Ingeborg Hartz; Anne Elise Eggen; Sameline Grimsgaard; Frode Skjold; Inger Njølstad
Journal:  Eur J Clin Pharmacol       Date:  2004-09-29       Impact factor: 2.953

5.  Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention.

Authors:  Atle Fretheim; Andrew D Oxman; Kari Håvelsrud; Shaun Treweek; Doris T Kristoffersen; Arild Bjørndal
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

6.  Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230].

Authors:  Atle Fretheim; Andrew D Oxman; Shaun Treweek; Arild Bjørndal
Journal:  BMC Health Serv Res       Date:  2003-02-27       Impact factor: 2.655

7.  Improving prescribing of antihypertensive and cholesterol-lowering drugs: a method for identifying and addressing barriers to change.

Authors:  Atle Fretheim; Andrew D Oxman; Signe Flottorp
Journal:  BMC Health Serv Res       Date:  2004-09-03       Impact factor: 2.655

8.  Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994-2003.

Authors:  Stefaan Bartholomeeusen; Jan P Vandenbroucke; Carla Truyers; Frank Buntinx
Journal:  BMC Fam Pract       Date:  2008-06-30       Impact factor: 2.497

Review 9.  Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials.

Authors:  Furio Colivicchi; Catarina Sternhufvud; Sanjay K Gandhi
Journal:  Clinicoecon Outcomes Res       Date:  2015-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.